Namasivayam Elangovan

MedicineBiochemistry, Genetics and Molecular BiologyEngineeringImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “A Multiwell-Plate Caenorhabditis elegans Assay for Assessing the Therapeutic Potential of Bacteriophages against Clinical Pathogens”.

A Multiwell-Plate Caenorhabditis elegans Assay for Assessing the Therapeutic Potential of Bacteriophages against Clinical Pathogens

Microbiology Spectrum(2022)10.1128/spectrum.01393-21

N/A

0DataRank · unranked

18 citations

Sebastián Leptihn, Namasivayam Elangovan, Archana Loganathan, Ramesh Nachimuthu, Prasanth Manohar

In vitro and in vivo evaluation of the biofilm-degrading Pseudomonas phage Motto, as a candidate for phage therapy

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.12.512010

N/A

0DataRank · unranked

1 citations

Belinda Loh, Dann Turner, Ramasamy Tamizhselvi, Marimuthu Mathankumar, Namasivayam Elangovan +3 more

A multiwell-plate Caenorhabditis elegans assay for assessing the therapeutic potential of Bacteriophages against Clinical Pathogens

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.05.474866

N/A

0DataRank · unranked

0 citations

Belinda Loh, Namasivayam Elangovan, Archana Loganathan, Ramesh Nachimuthu, Sebastián Leptihn +1 more

In vitro and in vivo evaluation of the biofilm-degrading Pseudomonas phage Motto, as a candidate for phage therapy

Frontiers in Microbiology(2024)10.3389/fmicb.2024.1344962

N/A

0DataRank · unranked

19 citations

Belinda Loh, Dann Turner, Ramasamy Tamizhselvi, Marimuthu Mathankumar, Namasivayam Elangovan +3 more